Baolingbao Biology002286.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 19, 2026, Baolingbao Biology (002286.SZ) trades at a P/E of 22.50x, P/B of 1.36x, P/S of 1.05x, and a dividend yield of 1.45%.
Longitudinal percentile comparison: P/E sits at the 12th percentile over the trailing 10Y window (vs. 14th percentile over 3Y); P/B sits at the 16th percentile over the trailing 10Y window (vs. 40th percentile over 3Y); P/S sits at the 10th percentile over the trailing 10Y window (vs. 30th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 26th percentile within its industry and the 30th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.45%, ranking at the 96th percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 4.0 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Baolingbao Biology operates in the Agriculture, Forestry, Animal Husbandry and Fishery sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 002286 · SZSE: 002286 · 002286
Want the full picture on whether Baolingbao Biology (002286.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 22.50 | ||||||
| P/B (MRQ) | 1.36 | ||||||
| P/S (TTM) | 1.05 | ||||||
| Dividend Yield | 1.45% | ||||||
| Buyback + Div Yield | 1.45% |